United States
Germany
Japan
United Kingdom
China
Antibodies
Recombinant Anti-CD4 (Clone 13B8.2)
| Applications | EIA, ELISA, FC, IHC, WB |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone MT310)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC |
| Reactivities | Human, Chimpanzee |
Recombinant Anti-CD4 (Clone YNB46.1.8 (Campath-9H))
| Applications | FC, IHC |
| Reactivities | Human |
Anti-CD4 Reference Antibody (ibalizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD4 Reference Antibody (Semzuvolimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-CD4 Reference Antibody (tregalizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-CD4 Reference Antibody (TRX1)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone 13B8.2)
| Applications | EIA, ELISA, FC, IHC, WB |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC |
| Reactivities | Human, Chimpanzee |
Recombinant Anti-CD4 (Clone DB81)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone DB81)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
